P355
A monoclonal human IgG1 phosphorylcholine antibody reduces vein graft remodelling, angiogenesis and intraplaque haemorrhage

Cardiovascular Research

23 April 2018

Organised by:

Read full article

Contributors

F Baganha

F Baganha

Author

M De Vries

M De Vries

Author

P Knutt

P Knutt

Author

PHA Quax

PHA Quax

Author

You may be interested in

Congress Presentation

Significant PD-ECGF and E-selectin induction in pathological remodeling of thoracic aortic tissue - target for a preventive cimetidine strategy

1 September 2025

Congress Presentation

INZ-701, a recombinant ENPP1-Fc protein, effectively treats and prevents neointimal proliferation in WT and ENPP1 Deficient mice

30 April 2022

Congress Session

Photon-counting CT in clinical practice: learn how much further you can go

11 May 2023

Congress Presentation

Antibodies against phosphorylcholine in prediction of cardiovascular disease among women: a population-based prospective cohort study.

30 August 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources